Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Sales | 3 | 7,014 | 12 | 10 | 0 |
| Cost of Goods | N/A | 1,050 | N/A | 0 | N/A |
| Gross Profit | 3 | 5,964 | 12 | 10 | N/A |
| Operating Expenses | 22,005 | 16,661 | 10,784 | 9,050 | 0 |
| Operating Income | -22,002 | -10,647 | -10,772 | -9,040 | N/A |
| Interest Expense | 212 | 383 | 14 | 0 | 0 |
| Other Income | 1,124 | 319 | 158 | -1,280 | 0 |
| Pre-tax Income | -21,090 | -10,711 | -10,628 | -10,320 | 0 |
| Net Income Continuous | -21,090 | -10,711 | -10,628 | -10,326 | N/A |
| Net Income | $-21,090 | $-10,711 | $-10,628 | $-10,320 | $N/A |
| EPS Basic Total Ops | -1,900.00 | -1,200.00 | -1,700.00 | -2,000.00 | N/A |
| EPS Basic Continuous Ops | -1,903.19 | -1,236.69 | -1,703.75 | -1,948.30 | N/A |
| EPS Diluted Total Ops | -1,900.00 | -1,300.00 | -1,700.00 | -2,000.00 | N/A |
| EPS Diluted Continuous Ops | -1,903.19 | -1,228.04 | -1,703.75 | -1,948.30 | N/A |
| EBITDA(a) | $-21,966 | $-10,620 | $-10,748 | $-9,020 | $N/A |